HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Mori Selected Research

Amyloid Plaque

8/2014Specific antibody binding to the APP672-699 region shifts APP processing from α- to β-cleavage.
2/2008CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation.
8/2001Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Mori Research Topics

Disease

42Neoplasms (Cancer)
03/2018 - 01/2000
12Infections
09/2017 - 01/2000
12Carcinoma (Carcinomatosis)
11/2010 - 03/2000
9Tuberculosis (Tuberculoses)
09/2011 - 08/2000
8Colorectal Neoplasms (Colorectal Cancer)
10/2016 - 10/2000
7Neoplasm Metastasis (Metastasis)
08/2014 - 10/2000
7Alzheimer Disease (Alzheimer's Disease)
08/2014 - 01/2000
6Leukemia
01/2018 - 02/2000
6Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 02/2007
6Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018 - 09/2003
5Melanoma (Melanoma, Malignant)
03/2018 - 09/2011
5Inflammation (Inflammations)
01/2018 - 08/2001
5Hepatocellular Carcinoma (Hepatoma)
07/2015 - 07/2001
5Carcinogenesis
08/2014 - 02/2000
5Adenocarcinoma
08/2001 - 03/2000
4Necrosis
05/2021 - 04/2005
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2018 - 08/2000
4Adenoma (Adenomas)
10/2016 - 01/2000
4Hypersensitivity (Allergy)
01/2016 - 07/2000
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2013 - 04/2000
4Dry Eye Syndromes (Dry Eye Syndrome)
07/2011 - 05/2001
4Ischemia
09/2009 - 02/2000
4Erythema
08/2005 - 07/2000
4Pneumoperitoneum
04/2005 - 04/2001
3Disease Progression
12/2018 - 04/2000
3Hematologic Neoplasms (Hematological Malignancy)
09/2017 - 01/2000
3Lymphatic Metastasis
08/2017 - 11/2000
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2015 - 04/2002
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2015 - 10/2009
3Hemangioma (Angioma)
09/2015 - 01/2009
3Hemangiosarcoma (Angiosarcoma)
09/2015 - 01/2009
3Amyloid Plaque
08/2014 - 08/2001
3Dementia (Dementias)
08/2014 - 03/2006
3Philadelphia Chromosome
06/2013 - 08/2000
3Sepsis (Septicemia)
04/2013 - 10/2001
3Pre-Eclampsia (Preeclampsia)
07/2012 - 05/2011
3Stomach Neoplasms (Stomach Cancer)
08/2011 - 04/2001
3Body Weight (Weight, Body)
11/2008 - 02/2001
3Lymphoma (Lymphomas)
08/2005 - 12/2000
3Obesity
10/2003 - 02/2000
3Adenomyosis
12/2001 - 10/2000
3Lung Neoplasms (Lung Cancer)
04/2001 - 01/2000
3Sarcoidosis (Schaumann Disease)
03/2001 - 03/2000
3Glioma (Gliomas)
09/2000 - 01/2000
3Glioblastoma (Glioblastoma Multiforme)
06/2000 - 01/2000
2Deglutition Disorders (Dysphagia)
01/2022 - 01/2022
2Pathologic Constriction (Stenosis)
01/2021 - 02/2000

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
03/2018 - 01/2000
9DNA (Deoxyribonucleic Acid)IBA
09/2015 - 06/2000
6AntigensIBA
09/2007 - 07/2000
5CytokinesIBA
08/2014 - 12/2001
5Tacrolimus (Prograf)FDA LinkGeneric
04/2014 - 05/2001
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2014 - 07/2000
5Cytarabine (Cytosar-U)FDA LinkGeneric
07/2011 - 04/2000
5AntibodiesIBA
02/2008 - 07/2000
4Indicators and Reagents (Reagents)IBA
01/2021 - 01/2000
4LipidsIBA
12/2018 - 02/2000
4CaspasesIBA
03/2018 - 06/2000
4Amyloid (Amyloid Fibrils)IBA
04/2017 - 08/2001
4Carrier Proteins (Binding Protein)IBA
12/2016 - 01/2000
4Immunoglobulin E (IgE)IBA
01/2016 - 05/2005
4Oxygen (Dioxygen)IBA
07/2012 - 02/2000
4Matrix Metalloproteinases (MMPs)IBA
01/2009 - 05/2001
4Adrenal Cortex Hormones (Corticosteroids)IBA
08/2008 - 03/2000
4Monoclonal AntibodiesIBA
01/2004 - 07/2000
4Anti-Bacterial Agents (Antibiotics)IBA
01/2003 - 05/2000
4Proliferating Cell Nuclear Antigen (PCNA)IBA
05/2002 - 01/2000
4Fluorouracil (Carac)FDA LinkGeneric
12/2001 - 12/2000
4Insulin (Novolin)FDA Link
12/2001 - 04/2000
3Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2021 - 04/2002
3SteroidsIBA
12/2018 - 07/2000
3Caspase 3 (Caspase-3)IBA
03/2018 - 06/2000
3Estrogens (Estrogen)FDA Link
01/2018 - 03/2000
3MicroRNAs (MicroRNA)IBA
12/2016 - 06/2013
3Biological ProductsIBA
12/2016 - 09/2000
3RNA (Ribonucleic Acid)IBA
12/2015 - 04/2000
3Peptides (Polypeptides)IBA
08/2014 - 01/2004
3Etoposide (VP 16)FDA LinkGeneric
07/2011 - 09/2000
3Methotrexate (Mexate)FDA LinkGeneric
10/2009 - 06/2000
3Pharmaceutical PreparationsIBA
11/2008 - 09/2000
3Interferon-gamma (Interferon, gamma)IBA
09/2008 - 08/2000
3VaccinesIBA
02/2008 - 04/2000
3Doxorubicin (Adriamycin)FDA LinkGeneric
02/2004 - 09/2000
3Messenger RNA (mRNA)IBA
12/2003 - 01/2000
3Prednisolone (Predate)FDA LinkGeneric
09/2003 - 04/2000
3NucleosidesIBA
12/2001 - 06/2000
3Protein Isoforms (Isoforms)IBA
05/2001 - 05/2000
2C-Reactive ProteinIBA
01/2022 - 04/2000

Therapy/Procedure

32Therapeutics
12/2018 - 01/2000
18Drug Therapy (Chemotherapy)
09/2017 - 01/2000
17Hematopoietic Stem Cell Transplantation
12/2018 - 05/2001
10Transplantation
01/2018 - 09/2003
8Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2009 - 12/2000
6Stem Cell Transplantation
10/2015 - 12/2000
5Stents
01/2021 - 02/2000
4Radiotherapy
07/2015 - 08/2001
3Cell Transplantation
09/2015 - 06/2013
3Injections
01/2014 - 08/2000
3Lymph Node Excision (Lymph Node Dissection)
05/2012 - 11/2010
3Laparotomy
01/2005 - 01/2000